Anne-Marie Birkill has an outstanding track record spanning three decades in research commercialisation and venture capital investment. 

With a passion for nurturing groundbreaking scientific ideas and transforming them into high-value game-changing solutions, in 2010 she co-founded OneVentures, a venture capital firm focused on investing in companies with innovative technologies. Some of the standout successes she has advanced include technologies in vaccine delivery, e-health and batteries.

Ms Birkill also serves as director and advisor for other companies; engaged widely with industry, universities and government; and has mentored many entrepreneurs, placing her at the heart of Australia’s innovation ecosystem. She is a champion for diversity, having co-founded Women in Biotechnology (later merged to become Women in Technology) and mentoring young women in venture capital including through the Australian Investment Council. 

Anne-Marie Birkill has an outstanding track record and impact spanning three decades in research commercialisation and venture capital investment. She co-founded OneVentures in 2010, a venture capital firm with >$700m in funds under management focussed on investing in companies with innovative technologies. Anne-Marie has contributed to the success of the OneVentures portfolio and many other companies as director and advisor. Her passion for ensuring Australia’s rich repository of research outcomes is translated into products and services is evident in her engagements with industry, universities, and government. Anne-Marie is a role model, mentor, and coach to many and a diversity champion.